{"id":349191,"date":"2024-10-20T00:35:20","date_gmt":"2024-10-20T00:35:20","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-en-iso-116152012\/"},"modified":"2024-10-26T00:14:46","modified_gmt":"2024-10-26T00:14:46","slug":"bs-en-iso-116152012","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-en-iso-116152012\/","title":{"rendered":"BS EN ISO 11615:2012"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
7<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
8<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | 1\tScope 2\tNormative references 3\tTerms, definitions and abbreviations 3.1\tTerms and definitions <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 3.2\tAbbreviations <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | 4\tRequirements 4.1\tConcepts required for the unique Identification of Medicinal Products <\/td>\n<\/tr>\n | ||||||
27<\/td>\n | 5\tDescription of the information modelling principles and practices 5.1\tGeneral considerations <\/td>\n<\/tr>\n | ||||||
28<\/td>\n | 5.2\tConceptual overview diagrams <\/td>\n<\/tr>\n | ||||||
29<\/td>\n | 5.3\tSection high-level diagrams <\/td>\n<\/tr>\n | ||||||
30<\/td>\n | 5.4\tDetailed description diagrams <\/td>\n<\/tr>\n | ||||||
33<\/td>\n | 6\tIdentifying characteristics for authorized Medicinal Products 6.1\tPrimary identifiers 6.2\tMedicinal Product Identifier (MPID) <\/td>\n<\/tr>\n | ||||||
34<\/td>\n | 6.3\tPackaged Medicinal Product Identifier (PCID) <\/td>\n<\/tr>\n | ||||||
35<\/td>\n | 6.4\tMedicinal Product Batch Identifier (BAID_1) 6.5\tMedicinal Product Batch Identifier (BAID_2) 7\tInformation for an authorized Medicinal Product 7.1\tAuthorized Medicinal Product\u00a0\u2014 Information overview <\/td>\n<\/tr>\n | ||||||
37<\/td>\n | 7.2\tMedicinal Product <\/td>\n<\/tr>\n | ||||||
42<\/td>\n | 7.3\tMarketing Authorization <\/td>\n<\/tr>\n | ||||||
48<\/td>\n | 7.4\tOrganization <\/td>\n<\/tr>\n | ||||||
50<\/td>\n | 7.5\tManufacturer\/Establishment <\/td>\n<\/tr>\n | ||||||
51<\/td>\n | 7.6\tPackaged Medicinal Product, including Manufactured Item and Device <\/td>\n<\/tr>\n | ||||||
60<\/td>\n | 7.7\tIngredient, Substance and Strength <\/td>\n<\/tr>\n | ||||||
64<\/td>\n | 7.8\tPharmaceutical Product and Device <\/td>\n<\/tr>\n | ||||||
68<\/td>\n | 7.9\tClinical Particulars <\/td>\n<\/tr>\n | ||||||
76<\/td>\n | 8\tIdentifying characteristics for Investigational Medicinal Products 8.1\tGeneral 8.2\tPrimary identifiers <\/td>\n<\/tr>\n | ||||||
77<\/td>\n | 8.3\tInvestigational Medicinal Product Identifier (IMPID) <\/td>\n<\/tr>\n | ||||||
78<\/td>\n | 8.4\tInvestigational Medicinal Product Package Identifier (IPCID) 8.5\tInvestigational Medicinal Product Batch Identifier (IBAID_1) 8.6\tInvestigational Medicinal Product Batch Identifier (IBAID_2) <\/td>\n<\/tr>\n | ||||||
79<\/td>\n | 9\tInformation for an Investigational Medicinal Product 9.1\tConceptual overview of the information for an Investigational Medicinal Product <\/td>\n<\/tr>\n | ||||||
80<\/td>\n | 9.2\tInvestigational Medicinal Product <\/td>\n<\/tr>\n | ||||||
82<\/td>\n | 9.3\tClinical Trial Authorization <\/td>\n<\/tr>\n | ||||||
85<\/td>\n | 9.4\tManufacturer\/Establishment 9.5\tInvestigational Packaged Medicinal Product <\/td>\n<\/tr>\n | ||||||
86<\/td>\n | 9.6\tPharmaceutical Product <\/td>\n<\/tr>\n | ||||||
87<\/td>\n | 9.7\tIngredient 9.8\tClinical particulars <\/td>\n<\/tr>\n | ||||||
88<\/td>\n | Annex\u00a0A \n(informative)<\/p>\n Full model\u00a0\u2014 Authorized Medicinal Products conceptual level <\/td>\n<\/tr>\n | ||||||
89<\/td>\n | Annex\u00a0B \n(informative)<\/p>\n Full model\u00a0\u2014 Authorized Medicinal Products detailed diagram <\/td>\n<\/tr>\n | ||||||
90<\/td>\n | Annex\u00a0C \n(informative)<\/p>\n Full model\u00a0\u2014 Investigational Medicinal Products conceptual level <\/td>\n<\/tr>\n | ||||||
91<\/td>\n | Annex\u00a0D \n(informative)<\/p>\n Full Model\u00a0\u2014 Investigational Medicinal Products detailed diagram <\/td>\n<\/tr>\n | ||||||
92<\/td>\n | Annex\u00a0E \n(informative)<\/p>\n Worked example in tabular form <\/td>\n<\/tr>\n | ||||||
101<\/td>\n | Annex\u00a0F \n(informative)<\/p>\n Class and attribute listing <\/td>\n<\/tr>\n | ||||||
115<\/td>\n | Annex\u00a0G \n(informative)<\/p>\n Example implementation of Medicinal Product information <\/td>\n<\/tr>\n | ||||||
123<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Health informatics. Identification of medicinal products. Data elements and structures for the unique identification and exchange of regulated medicinal product information<\/b><\/p>\n |